Stone et al (2002) confirmed which the α1A adrenergic receptor antagonist WB4101 as well as α1D antagonist BMY7378 had minimal impact on the rise in motor activity brought on by modafinil, but terazosin, which blocks α1A, α1D, and α1B receptors substantially attenuated